Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116

K-Number: K904004 · 1990-12-11

ApplicantAmresco, Inc.
Decision Date1990-12-11
Product CodeCGS
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116 is the device name listed in this FDA 510(k) record. The listed applicant is Amresco, Inc.. It received FDA 510(k) clearance on 1990-12-11 under 510(k) number K904004. The device is classified under product code CGS. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116?

AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116 is a medical device that received FDA 510(k) clearance on 1990-12-11. The listed applicant is Amresco, Inc.. The 510(k) number is K904004.

When did AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116 receive FDA 510(k) clearance?

AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116 received FDA 510(k) clearance on 1990-12-11, under 510(k) number K904004.

Who is the listed applicant for AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116?

The FDA 510(k) record lists Amresco, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116?

The FDA product code for AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116 is CGS.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Amresco, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K905618GGT REAGENTK904468DIRECT BILIRUBIN REAGENT, 7776/7777/7576/7476/7176K905684ALKALINE PHOSPHATASEK905544MAGNESIUM REAGENTK905284HDL-CHOLESTEROL PRECIPITANT 7773/7573/7473/7173K905096GGT REAGENTS, 7738, 7739, 7538, 7438 & 7138

View all 39 devices →

Related Devices (Code: CGS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K191296Pointe Scientific Creatinine Kinase (CK) Reagent SetMedtest DXK182702SEKURE Creatine Kinase AssaySekisui Diagnostics P.E.I., Inc.K160724ADVIA Chemistry Creatine Kinase (CK_L) Assay, ADVIA Chemistry Enzyme 3 CalibratorSiemens Healthcare Diagnostics, Inc.K123977RANDOX LIQUID CK-MB, RANDOX CK-MB CALIBRATORRandox Laboratories, Ltd.K112416CPK REAGENTVital Diagnostics (Manufacturing) PtyltdK083465DIMENSION VISTA CREATINE KINASE FLEX REAGENT CARTRIDGE AND DIMENSION VISTA CREATINE KINASE MB FLEX REAGENT CARTRIDGESiemens Healthcare Diagnostics

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑